AngioDynamics Inc (FRA:UG2)
€ 6.15 -0.1 (-1.67%) Market Cap: 251.87 Mil Enterprise Value: 205.71 Mil PE Ratio: 0 PB Ratio: 1.41 GF Score: 66/100

AngioDynamics Inc Investor and Technology Day (Virtual) Transcript

Jul 13, 2021 / 01:30PM GMT
Release Date Price: €23.2 (-1.69%)
Stephen A. Trowbridge
AngioDynamics, Inc. - Executive VP & CFO

Good morning, and welcome to AngioDynamics Investor and Technology Day. I'm so glad that you could join us this morning. My name is Stephen Trowbridge, I'm the Executive Vice President and Chief Financial Officer here at AngioDynamics. I've been with this company for over 13 years, and I'll tell you, I have never been more excited about our future opportunities than I am today.

So we're really excited to tell you about our products the markets that we're going into and our strategic transformation. We will be joined today by many members of our team, and they're going to take the opportunity to talk about the fast-growing, high-margin markets that we're going to be taking our products into.

We're going to be joined by Jim Clemmer, our President and CEO. Jim is going to talk about the strategic transformation that AngioDynamics has undertaken and how we're going to be looking at 3 main growth drivers that we call our MedTech products. And those growth drivers are going to be mechanical thrombectomy, peripheral

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot